1
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
2
|
Human herpesvirus 8 infection within families in rural Tanzania.
|
J Infect Dis
|
2003
|
2.42
|
3
|
Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.
|
J Infect Dis
|
2007
|
2.17
|
4
|
No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population.
|
AIDS
|
2008
|
1.99
|
5
|
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.
|
J Infect Dis
|
2007
|
1.88
|
6
|
Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
|
Carcinogenesis
|
2006
|
1.83
|
7
|
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
|
Blood
|
2011
|
1.81
|
8
|
Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
|
Gastroenterology
|
2006
|
1.81
|
9
|
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
|
Cancer Lett
|
2011
|
1.71
|
10
|
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
|
Clin Infect Dis
|
2010
|
1.70
|
11
|
Mother-to-child transmission of human herpesvirus-8 in South Africa.
|
J Infect Dis
|
2004
|
1.64
|
12
|
Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco.
|
J Infect Dis
|
2003
|
1.62
|
13
|
Host immunogenetics and control of human herpesvirus-8 infection.
|
J Infect Dis
|
2006
|
1.52
|
14
|
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda.
|
J Acquir Immune Defic Syndr
|
2013
|
1.51
|
15
|
Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers.
|
J Acquir Immune Defic Syndr
|
2005
|
1.51
|
16
|
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
|
AIDS
|
2003
|
1.49
|
17
|
Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection.
|
Clin Vaccine Immunol
|
2009
|
1.45
|
18
|
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
|
Int J Cancer
|
2004
|
1.32
|
19
|
Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1.
|
J Virol
|
2005
|
1.30
|
20
|
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain.
|
Int J Cancer
|
2002
|
1.27
|
21
|
Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda.
|
J Natl Cancer Inst
|
2003
|
1.26
|
22
|
Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission.
|
J Infect Dis
|
2009
|
1.24
|
23
|
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
|
Blood
|
2013
|
1.23
|
24
|
Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population.
|
J Acquir Immune Defic Syndr
|
2007
|
1.22
|
25
|
Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.
|
J Infect Dis
|
2009
|
1.22
|
26
|
Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda.
|
J Infect Dis
|
2004
|
1.21
|
27
|
Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.
|
J Infect Dis
|
2006
|
1.21
|
28
|
Sexually transmissible infections and prostate cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.21
|
29
|
Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria.
|
AIDS
|
2002
|
1.17
|
30
|
Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
|
Cancer
|
2006
|
1.17
|
31
|
Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.16
|
32
|
High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs.
|
J Infect Dis
|
2005
|
1.16
|
33
|
Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
|
Blood
|
2005
|
1.14
|
34
|
Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G.
|
J Clin Microbiol
|
2006
|
1.13
|
35
|
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
|
J Clin Oncol
|
2012
|
1.09
|
36
|
Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.
|
J Immunol Methods
|
2010
|
1.09
|
37
|
Kaposi's sarcoma-associated herpesvirus transmission and primary infection.
|
Curr Opin HIV AIDS
|
2009
|
1.08
|
38
|
A pilot study of cidofovir in patients with kaposi sarcoma.
|
J Infect Dis
|
2002
|
1.07
|
39
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
|
Haematologica
|
2007
|
1.07
|
40
|
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
|
Am J Clin Pathol
|
2013
|
1.06
|
41
|
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.
|
Transplantation
|
2008
|
1.06
|
42
|
Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.
|
Int J Cancer
|
2007
|
1.06
|
43
|
Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
|
J Infect Dis
|
2002
|
1.06
|
44
|
Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology.
|
Ann Epidemiol
|
2010
|
1.02
|
45
|
Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA.
|
AIDS
|
2003
|
1.00
|
46
|
Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
|
Mod Pathol
|
2003
|
0.99
|
47
|
One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
|
Hum Genet
|
2007
|
0.98
|
48
|
Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
|
Haematologica
|
2007
|
0.98
|
49
|
Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models.
|
Biostatistics
|
2007
|
0.95
|
50
|
Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa.
|
Infect Agent Cancer
|
2011
|
0.95
|
51
|
Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan.
|
Int J Cancer
|
2006
|
0.93
|
52
|
Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.93
|
53
|
Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
|
J Clin Virol
|
2006
|
0.93
|
54
|
Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt.
|
Emerg Infect Dis
|
2008
|
0.92
|
55
|
Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers.
|
Arch Dermatol
|
2005
|
0.91
|
56
|
Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity.
|
J Virol
|
2013
|
0.88
|
57
|
Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: seroprevalence and associated factors.
|
J Med Virol
|
2007
|
0.87
|
58
|
Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.87
|
59
|
Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions.
|
Cancer Lett
|
2008
|
0.87
|
60
|
Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.
|
Infect Agent Cancer
|
2010
|
0.86
|
61
|
Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.
|
J Infect Dis
|
2010
|
0.85
|
62
|
Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia.
|
Sex Health
|
2005
|
0.85
|
63
|
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
|
J Infect Dis
|
2012
|
0.84
|
64
|
Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily.
|
J Med Virol
|
2009
|
0.84
|
65
|
Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma.
|
Int J Epidemiol
|
2005
|
0.83
|
66
|
Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
|
AIDS
|
2004
|
0.83
|
67
|
Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.
|
J Acquir Immune Defic Syndr
|
2013
|
0.82
|
68
|
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
|
AIDS
|
2015
|
0.81
|
69
|
Age of infection and risk of virally associated cancers: new clues to an old puzzle.
|
J Infect Dis
|
2012
|
0.81
|
70
|
Human herpesvirus 8 seroprevalence among children and adolescents in the United States.
|
Pediatr Infect Dis J
|
2008
|
0.81
|
71
|
Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City.
|
Int J Epidemiol
|
2002
|
0.80
|
72
|
Searching for targets of viral microRNAs.
|
Nat Genet
|
2009
|
0.79
|
73
|
Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis.
|
Semin Arthritis Rheum
|
2008
|
0.78
|
74
|
Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area.
|
Invest Clin
|
2009
|
0.78
|
75
|
A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.78
|
76
|
Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
|
Int J Cancer
|
2014
|
0.77
|
77
|
Viruses and kidney disease: beyond HIV.
|
Semin Nephrol
|
2008
|
0.76
|
78
|
Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease.
|
Cancer Prev Res (Phila)
|
2010
|
0.75
|
79
|
Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.
|
Diagn Microbiol Infect Dis
|
2013
|
0.75
|
80
|
A Unique Case of Classic Kaposi's sarcoma restricted to the toes.
|
J Dermatol Case Rep
|
2013
|
0.75
|
81
|
Human papillomavirus false positive cytological diagnosis in low grade squamous intraepithelial lesion.
|
Invest Clin
|
2009
|
0.75
|
82
|
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma.
|
Transplantation
|
2010
|
0.75
|